Company Announcements

Analytik Jena’s revenues for the fiscal year ended September 30, 2008, increased 23.1% organically to €53.1 million ($79.2 million) (see IBO 12/31/08). Analytical Solutions sales rose 23.3%, Bio Solutions sales grew 35.1% and Optical Solutions sales grew 16.9% to represent 76%, 8% and 16% of sales, respectively. Including the discontinued Project Solutions unit, German sales rose 15.2%, European sales fell 18.0%, American sales grew 15.9%, Asian sales increased 28.7% and Rest of World sales fell 38.5%.

Illumina named Bill Bonnar senior vice president of Operations in January. He previously served in several senior operations management positions at KLA-Tencor.

In January, Teledyne Tekmar announced that SCI-CON will be its representative for the Southeastern US.

Danaher appointed David Martyr, who oversees Danaher’s Life Sciences business, and Jonathan Clark, whose responsibilities include all of Hach-Lange’s operations, as vice presidents and group executives.

Danaher reported that sales for its Environmental platform grew 7.5% for the fourth quarter 2008 and 15.5% for the year. Core revenues rose 6.5% for each period. Water Quality core revenue grew in the high single digits for the quarter, with Chinese sales up more than 20%. Ultra Pure analytical solutions revenue grew in the mid-teens for the quarter. Core revenue for Danaher’s Leica business increased in the high single digits for the quarter, driven by sales of confocal microscopes, as well as 20% growth for Leica Biosystems’ pathology diagnostic business.

James Mazzo resigned from Beckman Coulter’s Board due to Abbott Laboratories’ purchase of Advanced Medical Optics, where he is chairman, president and CEO.

QIAGEN named Stephane Perrey, PhD, president of QIAGEN Japan in January. He joins the company from Third Wave/Hologic Japan. QIAGEN KK employs a staff of 80 and generated revenues of $40 million last year.

In January, Horiba introduced Horiba Scientific, a global team that integrates the expertise and resources of Horiba Group companies.

MDS Analytical Technologies’ net revenues for the year ended October 31, 2008, rose 24.1% to $437 million (see IBO 1/31/09), including $83 million in sales from Molecular Devices. Organically, sales declined 1%. End-user revenue for MS products rose 2% and end-user MS service revenue grew 19%, but end-user MS unit shipments fell 3%. Total sales of bioresearch and drug discovery product lines grew 60%, but were flat in the fourth quarter. R&D rose 18.8% to $76 million, but MS R&D was down over 20%. For joint ventures, revenue declined 27.3% to $149 million and equity earnings fell 7.5% to $49 million.

Sales/Orders of Note

In January, testing services company Intertek selected PerkinElmer as its preferred vendor for the majority of its instrumentation requirements worldwide, which includes more than 1,000 sites.